Philippa C Matthews
Overview
Explore the profile of Philippa C Matthews including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
176
Citations
5617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maponga T, McNaughton A, Campbell C, de Cesare M, Mokaya J, Lumley S, et al.
Ann Hepatol
. 2025 Feb;
:101763.
PMID: 39986372
Introduction And Objectives: Chronic hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC). In African populations, HCC frequently presents at an advanced stage with poor...
2.
Lumley S, Kent C, Jennings D, Chai H, Airey G, Waddilove E, et al.
Sci Rep
. 2025 Feb;
15(1):5795.
PMID: 39962085
Hepatitis B virus (HBV) whole genome sequencing (WGS) is currently limited as the DNA viral loads (VL) of many clinical samples are below the threshold required to generate full genomes...
3.
Mashilo A, Mompati I, Ramakatane R, Sebitloane D, Sibi N, Matthews P, et al.
Afr J Prim Health Care Fam Med
. 2025 Feb;
17(1):e1-e8.
PMID: 39935120
Background: Hepatitis B virus (HBV), a significant cause of liver disease globally, is recognised as a 2030 elimination target by the World Health Organization (WHO). Healthcare workers (HCWs) require appropriate...
4.
Wang S, Harrington M, Graham C, Downs L, Kagwanja N, Etyang A, et al.
Lancet Gastroenterol Hepatol
. 2025 Feb;
10(4):291-292.
PMID: 39923777
No abstract available.
5.
Matthews P, Wang T, Barnes E
JHEP Rep
. 2025 Jan;
7(2):101280.
PMID: 39867684
No abstract available.
6.
Swets M, Kerr S, Mackenna B, Fisher L, van Wijnen M, Brandwagt D, et al.
JMIR Public Health Surveill
. 2025 Jan;
10:e55376.
PMID: 39864403
Background: In March 2022, a concerning rise in cases of unexplained pediatric hepatitis was reported in multiple countries. Cases were defined as acute hepatitis with serum transaminases >500 U/L (aspartate...
7.
Wang T, Campbell C, Stockdale A, Todd S, McIntyre K, Frankland A, et al.
JHEP Rep
. 2024 Dec;
7(1):101229.
PMID: 39717508
Background & Aims: The dynamics of HBV viral load (VL) in patients with chronic hepatitis B (CHB) on nucleos(t)ide analogue (NA) treatment and its relationship with liver disease are poorly...
8.
Jemutai J, Downs L, Anderson M, Cohen C, Seeley J, Sultan B, et al.
Lancet Gastroenterol Hepatol
. 2024 Dec;
10(2):100-103.
PMID: 39681128
No abstract available.
9.
Inzaule S, Easterbrook P, Latona A, Ford N, Irving W, Matthews P, et al.
Clin Infect Dis
. 2024 Oct;
79(6):1437-1446.
PMID: 39361017
Background: The advent of short-course, curative treatment with direct-acting antivirals (DAA) has given promise for the global elimination of hepatitis C virus (HCV) infections by 2030. Virological failure occurs in...
10.
Frampton S, Orievulu K, Matthews P, Giubilini A, Hordern J, Burns L, et al.
Front Public Health
. 2024 Sep;
12:1394569.
PMID: 39220463
Whilst many lessons were learned from the COVID-19 pandemic, ongoing reflection is needed to develop and maintain preparedness for future outbreaks. Within the field of infectious disease and public health...